INTRODUCTION
The reverse transcriptase (RT) enzyme of the human immunodeficiency virus type 1 (HIV-1) carries out reverse transcription of the viral RNA genome (1) . Reverse transcription is primed by a tRNA lys3 molecule that is bound to the primer-binding site (PBS), which is located in the 5′ half of the viral RNA. With the tRNA as a primer and the viral RNA as template, a (-) strand cDNA is synthesized up to the 5′-terminus of the template (Fig. 1 ). This product is termed the (-) strand strong stop DNA or (-)ssDNA. Because of the presence of a repeat sequence (R) at both ends of the viral RNA, DNA synthesis can continue upon hybridization of this (-)ssDNA to the 3′-located R region in the first strand transfer step (2) . Reverse transcription can subsequently elongate over the RNA template to generate a full-length (-) strand cDNA. During elongation of the polymerase the RNA strand is degraded by the intrinsic RNase H activity of the RT enzyme, resulting in a single-stranded (-)ssDNA copy which serves as a template for (+) strand DNA synthesis. At least two purine-rich RNA sequences, located in the middle and 3′ half of the genome, resist RNase H activity and these RNA fragments serve as primers for (+) strand DNA synthesis (3) . A second strand transfer step is required at this point to produce a full-length double-stranded DNA copy. The double-stranded DNA is integrated into the host genome and is recognized by the host transcription machinery for the production of new viral RNA genomes.
Actinomycin D (ActD) is a widely used antibiotic and anti-cancer drug that specifically inhibits DNA-dependent DNA and RNA synthesis (4) (5) (6) . The drug interacts with single-and double-stranded DNA (5,7) and RNA-DNA hybrids (8) , but not with RNA (9) . Furthermore, ActD can inhibit the annealing of DNA to complementary DNA or RNA (9) . It was recently demonstrated that ActD also inhibits elongation of DNA-dependent DNA synthesis by the HIV-1 RT enzyme (5) . In addition, Guo et al. (10) demonstrated that ActD blocks the synthesis of a 'fold-back' product of the HIV-1 (-)ssDNA. In this study, we examined in more detail the effect of ActD on the process of reverse transcription in an in vitro strand transfer assay. It was found that ActD does not inhibit elongation during HIV-1 (-)ssDNA synthesis on RNA templates, but the subsequent strand-transfer reaction was strongly inhibited. Further analysis indicated that ActD binds to the (-)ssDNA, thereby blocking the ability of this DNA to hybridize to the acceptor RNA.
MATERIALS AND METHODS

RNA templates
Donor and acceptor RNA templates were generated with T7 polymerase on PCR-generated HIV-1 DNA fragments. The DNA fragments were generated by PCR (5 min at 95_C, 25 cycles of 1 min at 95_C, 1 min at 55_C and 2 min at 72_C and then 10 min at 72_C) with a pBluescript template containing the viral 5′ LTR-segment (11) . The donor DNA fragment (containing the HIV-1 sequence from +1/+290, which refer to the position on the HIV-1 RNA genome, Fig. 1 ) was generated with the primers T7-2 *To whom correspondence should be addressed. Tel: +31 20 5664822; Fax: +31 20 6916531; Email: b.berkhout@amc.uva.nl . The +1/+97 repeat region (R) is present in both templates. HIV-1 RT extends the lys3 primer up to the 5′ end of the donor RNA. The newly synthesized (-)ssDNA (marked ss) can transfer to the 3′ end of the acceptor RNA and subsequent reverse transcription will generate an extended transfer cDNA (marked T). The transfer reaction was monitored by separating the ss and T cDNAs products by denaturing PAGE.
and ADSD (Table 1 ) and the oligonucleotides T7-1 and T7-3 (Table 1) were used to generate the acceptor DNA fragment (position -54/+93, Fig. 1 ). The sense primers T7-1 and T7-2 contain the T7-RNA polymerase promoter consensus sequence to allow subsequent in vitro run-off transcription on the PCR generated DNA fragments. The antisense T7-3 oligonucleotide contains a poly(T) stretch that is transcribed into a poly(A) tail that mimics the 3′ end of the HIV-1 RNA genome.
Run-off transcription was carried out in a final volume of 50 µl (40 mM Tris-Cl pH 7.5, 2 mM Spermidine, 10 mM DTT, 12 mM MgCl 2 ) with 1 µg of the DNA fragment in the presence of 20 U RNasin (Promega), 50 U of T7 RNA polymerase and 150 nmol of each ribonucleotide. The reaction mixture was incubated for 4 h at 37_C and then a DNase I treatment was performed for 10 min at 37_C to remove the DNA template. The RNA transcripts were purified by phenol/chloroform extraction and ethanol precipitation according to (4) . The RNA was dissolved in 25 µl of renaturation buffer (0.1 M NaCl, 0.05 M Tris-Cl pH 7.5), heated for 2 min at 85_C, slowly cooled to room temperature and stored at -20_C.
Strand transfer reaction
Reactions were carried out in a final volume of 24 µl as follows. The donor template (15 fmol) was mixed with excess lys3 DNA primer (2.9 pmol; (13) . The final reaction mixture was incubated for 1 h at 37_C. Reverse transcription was terminated by the addition of 1 µl 0.5 M EDTA pH 8.0 and the cDNA products were ethanol precipitated and redissolved in formamide loading buffer (4) . The samples were analyzed by polyacrylamide gel electrophoresis (PAGE) on a 6% sequencing gel (4). A 35 S-labeled sequence reaction with the same lys3 primer and the pBluescript LTR plasmid was performed with the T7 sequenaset kit 2.0 according to the suppliers instructions (Amersham, Cleveland, OH) and run alongside to determine the size of the cDNA products.
We also analyzed the cDNA products by non-denaturing PAGE. To do so, the cDNA products were split into three 8 µl fractions after termination of the reverse transcription. One sample was prepared as described above for analysis on a 6% sequencing gel. One sample was diluted with 200 µl of TE buffer (10 mM Tris-Cl pH 8.0, 1 mM EDTA), extracted with the same volume of phenol/chloroform and ethanol precipitated according to (4) . The other cDNA sample was ethanol precipitated directly. The latter two samples were dissolved in non-denaturing loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF, 30% glycerol). The samples were run on a non-denaturing polyacrylamide gel [gel composition 6% acryl (19:1), 5% glycerol in 0.25× concentrated TBE buffer (22 mM Tris-borate, 0.63 mM EDTA)]. The bands were visualized with a PhosphorImager and analyzed with the image-quant program (Molecular Dynamics). 
RNase H activity assays
For the analysis of the RT-encoded RNase H activity we performed reverse transcription assays with a radiolabeled HIV-1 RNA template (position -54/368). The labeled RNA was synthesized on a DNA fragment that was generated by PCR with primers T7-1 and ADAUG (Table 1 ) with a pBluescript template containing the viral 5′ LTR-segment (11) . Transcription was performed in a final volume of 10 µl transcription buffer (40 mM Tris-Cl pH 7.5, 2 mM Spermidine, 10 mM DTT, 12 mM MgCl 2 , 60 nmol CTP, GTP, ATP and 20 pmol UTP) with 0.5 µg DNA as template and in the presence of 20 µCi of [α-32 P]UTP (3000 Ci/mmol), 10 U T7 RNA polymerase (Boehringer Mannheim, Germany) and 20 U RNase inhibitor for 2 h at 37_C. After DNase I treatment (10 min at 37_C), the transcription mixture was loaded onto a 6% sequencing gel and the full-length donor RNA fragment was excised from the gel and the gel slice was subsequently eluted in 450 µl elution buffer (0.3 M NaAc pH 5.2). The solution was phenol extracted and the RNA was ethanol precipitated (4). The transcript was dissolved in renaturation buffer as described above. This labeled RNA was used in standard reverse transcription assays and the degradation products were analyzed on denaturing PAGE.
DNA folding algorithm
Structure prediction and free-energy minimization were performed using the SantaLucia parameters (14, 15) .
RESULTS
ActD specifically inhibits strand transfer
We used an in vitro reverse transcription assay to analyze the effect of the intercalating agent ActD on the elongation properties of the HIV-1 RT enzyme and the ability to perform strand transfer. The assay is schematically depicted in Figure 1 and uses a donor RNA that mimics the HIV-1 5′ R-leader region (positions +1/+292) and an acceptor RNA that mimics the 3′ end of the viral genome (positions -54/+93). Extension of the lys3 primer (Table 1) by the RT enzyme on the donor template will generate a 202 nt cDNA that represents the (-)ssDNA. This cDNA can transfer onto the acceptor template and subsequent elongation of reverse transcription will yield a 266 nt cDNA. It has been reported previously that the addition of HIV-1 NCp7 protein greatly enhances the efficiency of the in vitro strand transfer reaction (10, 13, (16) (17) (18) (19) (20) , and we therefore included NCp7 in our experimental system. The effect of ActD on cDNA synthesis and strand transfer was tested at increasing concentrations of the intercalating drug. For comparison, a similar experiment was conducted with another intercalating agent, ethidium bromide (EtBr). EtBr, used frequently for analytical detection of nucleic acids, intercalates into doublestranded regions of RNA with a preference for sites adjacent to bulged nucleotides (21, 22) . The cDNA reaction products were separated on a 6% sequencing gel (Fig. 2) . Without an intercalating agent, the same amount of the (-)ssDNA product (marked ss) and the transfer product (marked T) were produced (Fig. 2, lanes 1 and  7) , besides a number of premature pause cDNA products. EtBr caused a gradual decrease in the amount of the larger cDNA products (Fig. 2, lanes 8-12) , indicating that intercalation of EtBr into the RNA template affects the elongation of HIV-1 RT. In contrast, ActD did not affect (-)ssDNA synthesis, but a dramatic decrease in the production of the transferred cDNA product was observed (Fig. 2, lanes 2-6) . These results indicate that EtBr blocks elongation of reverse transcription, whereas ActD inhibits the transfer reaction. The 50% inhibitory concentration (IC 50 ) of ActD in this in vitro strand transfer assay is ∼100 µM.
It is possible that the ActD effect is caused by an elongation problem that occurs at a specific nucleotide sequence of the acceptor RNA, immediately after the DNA transfer step has taken place. To exclude this possibility, a similar primer extension experiment was performed with an extended RNA template that fuses the donor and acceptor sequences (corresponding to positions -54/+290, Fig. 1 ). We detected no difference in the synthesis of full-length cDNA in the absence or presence of ActD (Fig. 3, lanes 1 and 2) . Thus, ActD inhibits the strand transfer reaction in a specific manner and does not influence the elongation properties of the HIV-1 RT polymerase on RNA templates.
During these experiments we observed that most of the (-)ssDNA was not able to perform strand transfer, even in the presence of NCp7. In contrast, strand-transfer is thought to be an efficient process in virus-infected cells, with the absence of significant amounts of (-)ssDNA intermediate. Low in vitro strand transfer efficiencies have been reported by other groups (2, 10, 13, (16) (17) (18) (19) (20) 23) and this problem could be partially overcome with an excess of acceptor RNA. However, we reasoned that the abundant (-)ssDNA signal may represent hybridization to an excess unused donor RNA because the (-)ssDNA has a higher basepair capacity with the donor RNA than with the acceptor RNA. Such a (-)ssDNA/donor RNA hybrid cannot participate in strand transfer and this duplex is expected to be relatively stable because the polymerase-independent RNase H activity of the RT enzyme is inefficient (18, 24) . To test this idea, in vitro strand transfer reactions were performed with various amounts of the donor template. As expected, the total amount of cDNA product was reduced by limitation of the amount of donor template (Fig. 4, lanes 1-5) . However, the relative strand transfer efficiency [i.e. the ratio of transfer product over (-)ssDNA] increased dramatically when less donor template was present, confirming that an excess of donor RNA is toxic for the strand transfer reaction. This result is consistent with the idea that the newly synthesized cDNA preferentially anneals with unused donor RNA. Thus, an efficient way to improve the strand transfer reaction is to reduce the amount of donor RNA, and not to increase the amount of acceptor RNA. The inhibitory effect of ActD was reproduced in this optimized strand transfer protocol (Fig. 4, lanes 6-10) . We used 15 fmol of donor RNA and 70 fmol of acceptor RNA in the subsequent strand transfer reactions.
ActD does not interfere with RNase H activity
A possible explanation for the inhibition of strand transfer by ActD is that it intercalates into the donor RNA/cDNA duplex that is formed during reverse transcription, thereby blocking RNase H action. It is known that the cDNA remains hybridized to the template RNA in the absence of RNase H activity, resulting in a complete block of cDNA transfer (25) (26) (27) . To test this possibility, we repeated the reverse transcription reaction with the lys3 primer on a radiolabeled RNA template to follow both the polymerasedependent and polymerase-independent RNase H action of HIV-1 RT in the presence of ActD. As a control we used a mutant HIV-1 RT enzyme with the E478Q substitution that specifically inactivates the RNase H domain (12, 28) .
We used a 428 nt HIV-1 RNA template (-54/+368) for the RNase H assay (Fig. 5, lane 2) . No degradation of the donor RNA template was observed with the RNase H-minus RT enzyme under all conditions tested (Fig. 5, lanes 4-7) . Significant RNA degradation was observed with the wild-type RT enzyme (Fig. 5,  lanes 8-11) . Without dNTPs (Fig. 5, lanes 8 and 9) , the polymerase-independent RNase H activity can only degrade the part of the RNA template that is annealed to the DNA primer, resulting in a 5′ and 3′ fragment of 254 and 174 nt, respectively (marked P 1 and P 2 ). We measured the polymerase-dependent RNase H activity in the presence of dNTPs (Fig. 5, lanes 10 and 11) . In vitro strand transfer reactions were performed with a 32 P-labeled donor RNA template (-54/368) as described in Materials and Methods. The wild-type HIV-1 RT enzyme was used in lanes 8-11. In lanes 4-7, a mutant HIV-1 RT (E478Q) with an inactive RNase H domain was used. The presence of dNTPs (100 mM) and ActD (50 µg/µl) is indicated above the lanes. The position of the input transcript (lane 2, donor RNA of 428 nt) and the specific degradation products P 1 and P 2 are indicated on the right (see text for details). The position of several marker transcripts (lanes 1-3) is indicated on the left (the length is presented in nucleotides).
Reverse transcription on the RNA template resulted in degradation of the 5′ fragment P 1 , but the 3′ fragment P 2 remained intact. Most importantly, there was no difference in the RNA degradation pattern in the absence or presence of ActD (Fig. 5, lanes 8 and 9 for the polymerase-independent reaction, lanes 10 and 11 for the polymerase-dependent reaction). These results show that ActD does not affect the RNase H activity of the RT enzyme.
Act binds the (-)ssDNA and prevents annealing to the acceptor RNA
We next tested whether ActD inhibits strand transfer by direct binding to the (-)ssDNA. To detect the putative DNA-ActD complexes, the labeled cDNA products of reverse transcription were analyzed by non-denaturing PAGE (Fig. 6A and C) . As a control, the cDNA samples were analyzed by standard denaturing PAGE (Fig. 6B) . As expected, (-)ssDNA is the major reaction product without acceptor RNA (Fig. 6B, lane 1) . Surprisingly, this (-)ssDNA appeared as two discrete bands on the native gel (Fig. 6A, lane 1) . These two signals may represent alternative conformations of the DNA that exhibit different gel migration properties. Alternatively, one of these signals may represent DNA that is bound to either protein or RNA, and these complexes should be stable enough to survive the conditions of electrophoresis. For instance, the (-)ssDNA may associate with the HIV-1 RT enzyme or the NC protein that are present in these reaction mixtures. To test this, duplicate samples were phenol-extracted before analysis on the native gel (Fig. 6A, lanes 5-8) . Removal of protein did not influence the typical two-band pattern observed for the (-)ssDNA (Fig. 6A, lane 5) . To test whether the (-)ssDNA was hybridized to a donor RNA fragment, we treated the sample with RNase A before gel analysis. This treatment did have no effect on the two-band pattern seen in the absence of ActD (Fig. 6C, lane 3) .
It is likely that the slow-migrating band represents the unfolded, linear DNA, whereas the fast-migrating band corresponds to a more compact, structured DNA conformer. Consistent with this idea, we observed a shift from the fast-to the slow-migrating DNA species upon heat-denaturation of the sample prior to electrophoresis (Fig. 6C, lane 5) . Similar results were obtained upon denaturation with formamide (results not shown). Thus, we conclude that the two differentially migrating signals represent alternative DNA conformations, and we will refer to these two (-)ssDNA signals as ss U (unfolded) and ss F (folded). In the presence of ActD, no effect on the efficiency of (-)ssDNA synthesis was observed by denaturing PAGE (Fig. 6B, lane 2) . However, native PAGE revealed a shift towards the slow-migrating, unfolded (-)ssDNA conformation (Fig. 6A, lane 2; Fig. 6C, lane 2) . This experiment suggests that ActD binds to (-)ssDNA, thereby interfering with formation of the structured DNA conformer. We think that binding of ActD to the DNA is not directly visible with this technique because the molecular weight of ActD is too small to cause a significant band shift.
We next performed strand transfer assays in the presence of the acceptor RNA, resulting in the synthesis of both the (-)ssDNA and the transfer product (Fig. 6B, lane 3) . On the native gel, these products appear as a high molecular weight smear (marked T in Fig. 6A, lane 3) . This smear represents cDNA/RNA duplexes, and no free (-)ssDNA was detected. The variation in molecular size is most likely because of differential extension of the cDNA and differential degradation of the RNA template by RNase H. Even though not all (-)ssDNA is extended by RT (Fig. 6B, lane 3) , the native gel indicates that all (-)ssDNA was complexed with acceptor RNA, as no free (-)ssDNA was observed. As expected, strand transfer was strongly reduced in the presence of ActD (Fig. 6B,  lane 4) . Interestingly, analysis of this sample on the native gel indicated that (-)ssDNA is abundantly present as free DNA, and not as a DNA-RNA duplex (Fig. 6A, lane 4) . This result confirms that ActD interferes with the strand transfer step. Consistent with the previous ActD experiment (Fig. 6A, lane 2) , the (-)ssDNA was found to be present predominantly in the unfolded conformation (Fig. 6A, lane 4) . These combined results indicate that ActD binds directly to the (-)ssDNA, thereby precluding both intramolecular basepairing (e.g. formation of the structured ss F conformation) and intermolecular basepairing with the acceptor RNA during strand transfer. 
DISCUSSION
It was recently demonstrated that ActD inhibits HIV-1 reverse transcription in an in vitro assay (10) . In this study, we used HIV-1 RNA transcripts and RT enzyme in a strand transfer assay to analyze the mechanism of ActD-mediated inhibition. The results of this in vitro study indicate that ActD blocks the annealing of the newly synthesized (-)ssDNA to the acceptor RNA. This result is consistent with the property of ActD to bind single-stranded DNA in a relatively sequence-independent manner (5,7). Interestingly, the HIV-1 (-)ssDNA is present in two forms on native polyacrylamide gels; a structured, fast-migrating species and a slow-migrating, unstructured DNA. ActD caused a shift from the folded conformation to the linear DNA form. We think that both ActD effects are caused by 'coating' of the (-)ssDNA with ActD, thereby blocking the basepairing potential of this DNA. The ActD-induced shift from the structured to the unstructured (-)ssDNA form indicates that ActD binds preferentially to the single-stranded DNA, which is in agreement with previous binding studies with ActD and its derivative 7-aminoactinomycin D (7). ActD is widely used in cDNA synthesis protocols to prevent self-priming of the cDNA, and it is generally thought that this ActD effect is due to inhibition of DNA-dependent DNA synthesis. It is possible that the 'cDNA-unwinding' activity of ActD contributes to this effect. Although speculative, it is possible that the structured conformation of the HIV-1 (-)ssDNA that we observed in this study plays a role is the strand transfer process. This idea will be tested in future experiments, and biochemical experiments should be performed to probe the actual structure of the HIV-1 (-)ssDNA. Preliminary computer-aided DNA folding studies with a single-stranded DNA basepairing algorithm indicated that the HIV-1 (-)ssDNA can form two hairpin structures that are the approximate 'mirror image' of the TAR and polyA hairpins encoded by the (+)strand HIV-1 RNA template (Fig. 7) . The G-U basepairs in the RNA (marked in the TAR and polyA hairpins) will produce C A mismatches in the (-)ssDNA, and the complement of a G-triplet within TAR is predicted to basepair with the complement of a C-triplet downstream of the polyA hairpin (both triplets are marked in grey). It is likely that this tandem hairpin cDNA structure corresponds to the ss F band that we observed on native gels (Fig. 6 ). This structure is in equilibrium with the unfolded ss U form, and ActD binding to the single-stranded DNA will cause a shift to the ss U form.
Several alternative mechanistic explanations for ActD-mediated inhibition of strand transfer were tested. For instance, it is possible that ActD inhibits elongation of reverse transcription. ActD has been shown to inhibit the DNA-dependent DNA polymerase activity of HIV-1 RT, which most likely reflects binding of ActD to the DNA template (5) . In this study, we measured no effect of ActD on the RNA-dependent DNA polymerase activity of HIV-1 RT, which is in agreement with the inability of ActD to interact with either single-stranded or double-stranded RNA (7, 9) . In contrast, the intercalator EtBr interacts with RNA and was found to block elongation of reverse transcription on RNA templates. Another possible ActD effect is on the intrinsic RNase H activity of the RT enzyme. If the donor RNA template is not properly removed, the (-)ssDNA will not be able to participate in strand transfer (25) (26) (27) . However, we measured no effect of ActD on the RNase H activity of the HIV-1 RT enzyme.
While this study was submitted for publication, a follow-up report of the Levin laboratory (29) presented similar results. ActD-mediated inhibition of the first strand transfer step was observed, and this effect was demonstrated to correlate with reduced annealing of the (-)ssDNA to the acceptor RNA. Combined with the results presented in this study, in particular the finding that ActD interacts with the unfolded (-)ssDNA, it is concluded that ActD specifically inhibits the cDNA strand transfer step of reverse transcription.
The effect of ActD on reverse transcription represents a new strategy to inhibit an essential step in the viral life cycle. In fact, ActD has been used in the early years of retrovirology to unravel the viral replication mechanism (30, 31) , and a block of reverse transcription at the level of the (-)ssDNA has been proposed in studies on the murine leukemia virus (9, 32) . Apparently, ActD can inhibit reverse transcription of a variety of retroviral species, which is consistent with the relatively sequence-independent binding of ActD to DNA (5,7). A major advantage of this antiviral strategy may be that the virus cannot develop resistance against a DNA-binding drug that acts in a sequence-independent manner. Although ActD is already being used in chemotherapy of certain tumors (33, 34) , there are obvious toxicity problems associated with the use of this drug. Derivatives of this drug could be synthesized and tested for improved inhibition and/or reduced cell toxicity. One way to improve the selectivity of such reagents is to improve the sequence-specificity of HIV-1 (-)ssDNA binding, perhaps by coupling of ActD to short oligonucleotides. At the same time, this approach will enhance the chances of virus escape through mutation of the target sequence. It is also possible to mimic the mode of ActD action by unrelated single-stranded DNA-binding molecules, e.g. proteins. In fact, inhibition of the strand transfer reaction by two different single-stranded DNA binding proteins has been reported (35) . In that study, experiments with single-stranded DNA binding proteins were performed as controls for the effect of NC protein, and the implications for inhibition of reverse transcription were not addressed. We propose that single-stranded DNA-binding molecules may be considered as a new class of antiretroviral agents.
In vitro strand transfer reactions measure the ability of a nascently synthesized cDNA to leave the donor RNA template and bind to an acceptor RNA, with subsequent elongation of reverse transcription. Such in vitro studies (2, 10, 36) have been hampered by the inefficiency of the strand transfer compared with the in vivo situation (17) . Several approaches have been used to optimize the strand transfer efficiency, e.g. by increasing the amount of acceptor RNA. We now present evidence that this reaction can simply be improved by limitation of the amount of donor RNA. In the presence of excess donor RNA, the newly synthesized (-)ssDNA will preferentially bind to any remaining donor RNA, instead of the acceptor RNA, because of greater basepairing complementarity. For instance, the HIV-1 (-)ssDNA can form 202 bp with donor RNA and only 93 bp with acceptor RNA (Fig. 1) . This preference for the donor RNA is even more striking if strand transfer occurs before the full-length (-)ssDNA is synthesized (37) . Such premature cDNA transfer will bias the donor RNA over the acceptor RNA because the donor transcript contains additional 3′ sequences that allow annealing of these short cDNAs (Fig. 1) .
The tendency of (-)ssDNA to transfer onto excess donor RNA may also explain in part the strict requirement for NCp7 protein in the in vitro strand transfer reaction. This protein has been shown to have RNA chaperone activity, thereby stimulating both nucleic acid melting and annealing (38) (39) (40) . Although it has been suggested that NC stimulates the annealing of (-)ssDNA onto the acceptor RNA (10, 13, 16, 36) we propose that a major contribution of NC in these in vitro assays is to melt the 'dead-end' duplexes formed between (-)ssDNA and excess donor RNA. Indeed, NCp7 is essential in transfer reactions with relatively large templates but the protein is less critical in assays with shorter templates that will form less stable duplexes (10, 17) . Thus, we speculate that NCp7 promotes strand transfer by allowing the dead-end (-)ssDNA/donor RNA duplexes to 'breath', allowing the formation of productive (-)ssDNA/acceptor RNA duplexes. The equilibria between the different nucleic acid forms will be shifted indefinitely towards the (-)ssDNA/acceptor RNA duplex when the RT enzyme reinitiates reverse transcription. Most importantly, we describe that the dead end (-)ssDNA/donor RNA product can be avoided by simply limiting the amount of donor RNA. This situation is fully consistent with reverse transcription as it occurs in infected cells because only two viral RNA genomes are present per virion particle.
